Whittier Trust CO Novavax Inc Transaction History

Whittier Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$6.81 - $9.74 $238 - $340	35 New	35 $0
Q2 2022 Jul 28, 2022	SELL	$36.28 - $75.29 $108 - $225	-3 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$69.73 - $142.9 $209 - $428	3 New	3 $0
Q3 2021 Nov 01, 2021	SELL	$177.8 - $270.58 $89,789 - $136,642	-505 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$121.0 - $257.67 $43,197 - $91,988	-357 Reduced 41.42%	505 $107,000
Q1 2021 Apr 26, 2021	BUY	$112.98 - $319.93 $88,915 - $251,784	787 Added 1049.33%	862 $156,000
Q4 2019 Jan 31, 2020	SELL	$3.69 - $5.22 $184 - $261	-50 Reduced 40.0%	75 $0
Q3 2019 Oct 18, 2019	SELL	$4.02 - $7.84 $200 - $392	-50 Reduced 28.57%	125 $1,000
Q2 2019 Jul 23, 2019	BUY	$4.93 - $12.2 $862 - $2,135	175 New	175 $1,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.